Literature DB >> 29735252

A single-institution experience with a brucellosis outbreak in the United States.

Riya Joseph1, Matthew P Crotty2, Jonathan Cho3, Marie H Wilson4, Jennifer Tran5, Joslyn Pribble6, Leigh Hunter1.   

Abstract

Human cases of brucellosis in the United States are primarily limited to imported infections or reservoirs. We describe a brucellosis outbreak involving 8 patients treated at a single hospital in the United States. Standardized precautionary microbiology processes and coordinated collaboration among hospital departments and local health departments assisted in optimally managing this disease at our institution.
Copyright © 2018 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Communicable diseases; infection control; microbiology

Mesh：

Substances：

Year:  2018        PMID： 29735252     DOI： 10.1016/j.ajic.2018.03.022

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN： 0196-6553            Impact factor:   2.918


  3 in total

1.  First Outbreak of Occupational Brucellosis Involving Multiple Clusters - Hubei Province, China, 2019.

Authors:  Zhong Zhang; Yeqing Tong; Xinjun Lei; Li Liu; Zhiqiang Deng; Fei Sun; Huilai Ma; Zhaorui Chang; Lijie Zhang; Huihui Liu; Qi Chen; Jianzhong Zheng; Haibing Chen; Ximei Sun; Yang Wu; Xuhua Guan
Journal:  China CDC Wkly       Date:  2020-09-25

2.  An Outbreak of Brucellosis: An Adult and Pediatric Case Series.

Authors:  Linda Hassouneh; Syeda Quadri; Patricia Pichilingue-Reto; Sujittra Chaisavaneeyakorn; James B Cutrell; Dawn M Wetzel; Ank E Nijhawan
Journal:  Open Forum Infect Dis       Date:  2019-08-30       Impact factor: 3.835

3.  Brucella suppress STING expression via miR-24 to enhance infection.

Authors:  Mike Khan; Jerome S Harms; Yiping Liu; Jens Eickhoff; Jin Wen Tan; Tony Hu; Fengwei Cai; Erika Guimaraes; Sergio Costa Oliveira; Richard Dahl; Yong Cheng; Delia Gutman; Glen N Barber; Gary A Splitter; Judith A Smith
Journal:  PLoS Pathog       Date:  2020-10-27       Impact factor: 6.823
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.